These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 39122559)

  • 1. Persistence of residual shunt at 6 and 12 months after transoesophageal echocardiography-guided percutaneous closure of a patent foramen ovale for cryptogenic stroke.
    Witte LS; El Bouziani A; Beijk MAM; Robbers-Visser D; Coutinho JM; Tijssen JGP; Straver B; Bouma BJ; de Winter RJ
    Heart; 2024 Sep; 110(19):1172-1179. PubMed ID: 39122559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term results of percutaneous closure of a patent foramen ovale guided by transoesophageal echocardiography in patients with cryptogenic stroke: a retrospective study.
    Guo Y; Shi Z; Zheng Y; Xie C; Yi J; Chen Z; Shu Y; Zhou D
    J Cardiothorac Surg; 2022 May; 17(1):96. PubMed ID: 35505434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcranial Doppler Screening for Patent Foramen Ovale Closure in Cryptogenic Strokes in Young: A Single Center Experience from South India.
    Bal D; Ahmed Shaikh AI; Rayani M; Aaron S; Thompson VS; Jose J; Krupa J; Benjamin RN; Rajkumar JL; Prabhakar AT
    J Assoc Physicians India; 2022 Oct; 70(10):11-12. PubMed ID: 37355867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual Shunt After Patent Foramen Ovale Closure and Long-Term Stroke Recurrence: A Prospective Cohort Study.
    Deng W; Yin S; McMullin D; Inglessis-Azuaje I; Elmariah S; Hung J; Lo EH; Palacios IF; Buonanno FS; Ning M
    Ann Intern Med; 2020 Jun; 172(11):717-725. PubMed ID: 32422058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of residual shunts after initial percutaneous patent foramen ovale closure: a single center experience with immediate and long-term follow-up.
    Diaz T; Cubeddu RJ; Rengifo-Moreno PA; Cruz-Gonzalez I; Solis-Martin J; Buonanno FS; Inglessis I; Palacios IF
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):145-50. PubMed ID: 20578100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between patent foramen ovale anatomical features and residual shunt after patent foramen ovale closure.
    Nakayama R; Takaya Y; Akagi T; Takemoto R; Haruna M; Nakashima M; Miki T; Nakagawa K; Toh N; Nakamura K
    Cardiovasc Interv Ther; 2024 Apr; 39(2):200-206. PubMed ID: 38265606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patent foramen ovale closure by using transesophageal echocardiography for cryptogenic stroke: single center experience in 132 consecutive patients.
    Han Y; Zhang X; Zhang F
    J Cardiothorac Surg; 2020 Jan; 15(1):11. PubMed ID: 31918738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors and clinical outcomes of residual shunt in patients undergoing percutaneous transcatheter closure of patent foramen ovale.
    Zajarias A; Thanigaraj S; Lasala J; Perez J
    J Invasive Cardiol; 2006 Nov; 18(11):533-7. PubMed ID: 17090816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk mitigation in divers with persistent (patent) foramen ovale.
    Wilmshurst P
    Diving Hyperb Med; 2019 Jun; 49(2):77-78. PubMed ID: 31177512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residual Shunt after Patent Foramen Ovale Device Closure in Patients With Cryptogenic Stroke: Serial Bubble Contrast Transesophageal Echocardiography Data.
    Moon J; Kim M; Oh PC; Shin DH; Park HM; Jo YY; Lee JS; Kang WC
    J Stroke Cerebrovasc Dis; 2019 Feb; 28(2):347-353. PubMed ID: 30396838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of residual shunt rate and complications across 6 different closure devices for patent foramen ovale.
    Gevorgyan Fleming R; Kumar P; West B; Noureddin N; Rusheen J; Aboulhosn J; Tobis JM
    Catheter Cardiovasc Interv; 2020 Feb; 95(3):365-372. PubMed ID: 31654558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saline contrast and colour Doppler transoesophageal echocardiography in detecting a patent foramen ovale and right-to-left shunts in stroke patients.
    Luotolahti M; Saraste M; Hartiala J
    Clin Physiol; 1995 May; 15(3):265-73. PubMed ID: 7621648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcranial Doppler quantification of residual shunt after percutaneous patent foramen ovale closure. Comparison of two devices.
    Sorensen SG; Aguilar H; McKnight WK; Thomas H; Muhlestein JB
    J Interv Cardiol; 2010 Dec; 23(6):575-80. PubMed ID: 20796165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of patent foramen ovale closure with no-device left behind: first-in-man percutaneous suture closure.
    Ruiz CE; Kipshidze N; Chiam PT; Gogorishvili I
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):921-6. PubMed ID: 18412251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of patent foramen ovale in cryptogenic transient ischaemic attack and non-disabling stroke at older ages: a population-based study, systematic review, and meta-analysis.
    Mazzucco S; Li L; Binney L; Rothwell PM;
    Lancet Neurol; 2018 Jul; 17(7):609-617. PubMed ID: 29887162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second transcatheter closure for residual shunt following percutaneous closure of patent foramen ovale.
    Susuri N; Obeid S; Ulmi M; Siontis GCM; Wahl A; Windecker S; Nietlispach F; Meier B; Praz F
    EuroIntervention; 2017 Sep; 13(7):858-866. PubMed ID: 28437244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residual shunt after patent foramen ovale closure: preliminary results from Italian patent foramen ovale survey.
    Caputi L; Butera G; Anzola GP; Carminati M; Carriero MR; Chessa M; Onorato E; Rigatelli G; Sangiorgi G; Santoro G; Spadoni I; Ussia GP; Vigna C; Zanchetta M; Parati E;
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e219-26. PubMed ID: 23352683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-Market Clinical Follow-Up With the Patent Foramen Ovale Closure Device IrisFIT (Lifetech) in Patients With Stroke, Transient Ischemic Attack, or Other Thromboembolic Events.
    Sievert K; Yu J; Bertog S; Hornung M; von Bardeleben RS; Gafoor S; Reinartz M; Matic P; Hofmann I; Grunwald I; Schnelle N; Sievert H
    Cardiovasc Revasc Med; 2021 Sep; 30():72-75. PubMed ID: 33097460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants and clinical significance of persistent residual shunting in patients with percutaneous patent foramen ovale closure devices.
    Shafi NA; McKay RG; Kiernan FJ; Silverman IE; Ahlquist M; Silverman DI
    Int J Cardiol; 2009 Nov; 137(3):314-6. PubMed ID: 19616327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of three echo-guidance techniques in percutaneous patent foramen ovale closure for stroke prevention: Conventional transoesophageal, microprobe transoesophageal and intracardiac echocardiography.
    Reibel I; Hauguel-Moreau M; Guedeney P; Hage G; Hammoudi N; Duthoit G; Zeitouni M; Lattuca B; Kernéis M; Collet JP; Silvain J; Montalescot G;
    Arch Cardiovasc Dis; 2023 Nov; 116(11):523-528. PubMed ID: 37838576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.